Ski and Snowboard Accident Case Study: Spinal Injury, Pain Management, and Pharmacy Lien

James Wong — Founder & CEO, LienScripts | March 4, 2026 | 8 min read

A snowboard collision on a resort slope caused a lumbar burst fracture requiring surgery and 15 months of medication management. This case study examines how a pharmacy lien covered the pharmaceutical treatment while the negligence claim against the resort and other skier proceeded.

Ski and snowboard accidents at resorts can produce severe spinal injuries, particularly when collisions involve high-speed impacts or falls onto hardpack terrain. The assumption of risk defense, common in ski resort litigation, makes strong medical documentation essential.

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

• Ski and snowboard collision cases involve assumption of risk analysis, which varies significantly by state
• Spinal burst fractures from snowboard impacts require surgical stabilization and extended pharmaceutical management
• A 15-month pharmacy lien documented the surgical recovery and neuropathic pain management trajectory
• LienScripts' MERIT (Medication Evaluation & Rationale for Injury Treatment) report connected each medication to the collision mechanism
• The defense asserted assumption of risk; the pharmacy record documented injury severity that exceeded inherent skiing risks

Case Background

Patient: Tyler B. (name changed), 29-year-old male, graphic designer

Incident: Tyler was snowboarding at a ski resort. While traversing a blue (intermediate) run, another skier — descending at high speed on the same run — lost control after jumping an unmarked terrain feature at the edge of the groomed trail and collided with Tyler from behind. The impact launched Tyler forward and he landed on his back on packed ice approximately 15 feet downhill.

Injuries: L1 burst fracture with retropulsed bone fragments approaching the spinal canal, posterior ligamentous complex disruption, and bilateral sacroiliac joint strain.

Initial Treatment: Ski patrol immobilized Tyler and transported him to the resort's base area, where an ambulance transferred him to a regional hospital. Imaging revealed the L1 burst fracture with partial canal compromise. He underwent posterior spinal fusion from T11 to L3 with pedicle screw instrumentation within 48 hours.

Insurance Situation: Tyler had an individual ACA marketplace plan with a high deductible. The plan covered the acute surgery but denied post-discharge pain management medications as "subject to step therapy" — requiring Tyler to fail on lower-tier medications before approving the agents his surgeon had prescribed.

Attorney: Brenda C. (name changed), a plaintiff attorney with ski resort litigation experience.

Legal Context

Multiple defendants. Brenda filed claims against both the other skier (for negligent skiing) and the resort (for failure to mark the terrain feature that contributed to the skier losing control).

Assumption of risk. The resort's primary defense was assumption of risk — that Tyler assumed the risk of collision by choosing to snowboard. Brenda argued that assumption of risk covers inherent skiing risks (variable terrain, falls) but does not cover risks created by the resort's negligence (unmarked obstacles) or another skier's reckless conduct.

The Pharmacy Lien: 15 Months of Coverage

Brenda enrolled Tyler in the LienScripts pharmacy lien program at the first post-operative spine follow-up. With insurance step therapy blocking his surgeon's prescription plan, the lien program provided immediate access to the prescribed medications.

Medication Timeline

Post-Surgical Acute Phase: Months 1-3

Oxycodone 10mg every 6 hours for acute post-spinal fusion pain. The L1 burst fracture with T11-L3 fusion produced significant post-surgical pain requiring higher-dose opioid management.

Methocarbamol 750mg four times daily for paraspinal muscle spasm throughout the fused segment. Spinal fusion creates compensatory muscle tension in the segments above and below the hardware.

Enoxaparin 40mg subcutaneous daily for DVT prophylaxis during the period of post-surgical immobility.

Colace (docusate sodium) 100mg twice daily for opioid-induced constipation — a standard concurrent prescription with opioid therapy.

Transition Phase: Months 4-8

Oxycodone tapered to 5mg every 8 hours by month 4, and discontinued by month 6. The pharmacy record documented the controlled, physician-supervised taper.

Gabapentin 300mg three times daily, titrated to 900mg three times daily for neuropathic pain. The L1 burst fracture with retropulsed fragments had caused nerve root irritation, producing radiculopathic pain in the bilateral lower extremities.

Celecoxib 200mg daily for anti-inflammatory management at the fusion site.

Tizanidine 4mg at bedtime replaced methocarbamol for nighttime muscle spasm management with a more targeted sedating effect.

According to James Wong, PharmD, founder of LienScripts, "Spinal fusion cases always involve a complex medication transition from acute opioid management to long-term neuropathic and anti-inflammatory therapy. The pharmacy record captures every step of that transition, creating a clinical timeline that no other evidence source can replicate."

Long-Term Management: Months 9-15

Duloxetine 60mg daily was added at month 9 for combined neuropathic pain and depression. Tyler had been unable to resume his active lifestyle — no snowboarding, limited exercise, and desk-only work — and the psychological impact was significant.

Topical diclofenac 1% gel applied to the lumbar region for localized pain during physical therapy.

Cyclobenzaprine 5mg as needed for episodic muscle spasm during more aggressive physical therapy.

By month 15, Tyler had regained functional capacity for daily activities and sedentary work but had permanent restrictions on high-impact activities. His spine surgeon documented the T11-L3 fusion as permanent and projected a need for ongoing pain management.

How Pharmacy Documentation Supported the Case

The assumption of risk defense required Brenda to prove that Tyler's injuries exceeded what is inherent to snowboarding. The 15-month pharmaceutical record — documenting spinal fusion recovery, neuropathic complications, and permanent activity restrictions — established injury severity that went far beyond typical skiing bruises or sprains.

The MERIT report connected every medication to the specific collision mechanism and surgical interventions, making it clear that the injury was caused by the other skier's negligence and the resort's failure to mark the terrain feature.

Settlement Outcome

The case settled with contributions from both the other skier's homeowner's insurance and the resort's commercial liability policy. The comprehensive pharmaceutical documentation was central to establishing the severity of the injuries and justifying the settlement value.

Related Resources

• Medications for Back Injury After Accident
• What Is a MERIT Report?
• Long-Tail Medication Cases